Benzinga's Top Pre-Market NASDAQ Gainers (RBCN, OREX, ISPH, BRCD)

Rubicon Technology Inc RBCN rose 22.64% to $25.89 in the pre-market session. RBCN reported better-than-expected Q4 results. Orexigen Therapeutics Inc OREX added 5.88% to $3.60 in the pre-market session. OREX shares have dropped 47.37% over the past 52 weeks, while the S&P 500 index has gained 21.54% in the same period. Inspire Pharmaceuticals Inc ISPH soared 4.27% to $4.40 in the pre-market trading. ISPH announced its plans to cut around 27% of its workforce related to the cystic fibrosis drug's development. Brocade Communications Systems Inc BRCD moved up 1.57% to $5.81 in the pre-market session. BRCD is scheduled to report its quarterly earnings today. Read more from Benzinga's Markets.